TELA Bio Reports Fourth Quarter and Full Year 2022 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- AI stocks lift Wall St as oil falls, Treasury yields decline
- Oil prices slide to 11-day low on hopes of US-Iran diplomacy, Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- Qatar Investment Authority targets $20B partnership with JPMorgan - Bloomberg
- AMD stock jumps as chip rally builds ahead of summit
- Novo Nordisk shares drop as investor event disappoints
TELA Bio, Inc. (TELA) Tops Q4 EPS by 1c, Offers Guidance
March 21, 2023 4:13 PM EDTTELA Bio, Inc. (NASDAQ: TELA) reported Q4 EPS of ($0.52), $0.01 better than the analyst estimate of ($0.53). Revenue for the quarter came in at $11.6 million versus the consensus estimate of $13.18 million.
GUIDANCE:
TELA Bio, Inc. sees Q1 2023 revenue of $60-65 million, versus the... More
